Lec 14 - TEDxCaltech - Mark E. Davis - Nanomedicines: Nanobiotech v. Cancer. Mark E. Davis is the Warren and Katharine Schlinger Professor of Chemical Engineering at Caltech and a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope. He has over 350 scientific publications, two textbooks, and over 50 patents. He is the recipient of numerous awards, and was the first engineer to win the NSF Alan T. Waterman Award. He was elected in the National Academy of Engineering in 1997 and the National Academy of Sciences in 2006. Mark's research efforts involve materials synthesis in two general areas; namely, solids that can be used for molecular recognition and catalysis, and polymers for the delivery of a broad range of therapeutics. He is the founder of two biotech companies. Professor Davis has achieved All American Status for Masters Track and Field in both the 400 Meter and 200 Meter Dashes. About TEDx, x = independently organized event: In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized. (Subject to certain rules and regulations.) On January 14, 2011, Caltech hosted TEDxCaltech, an exciting one-day event to honor Richard Feynman, Nobel Laureate, Caltech physics professor, iconoclast, visionary, and all-around "curious character." Visit TEDxCaltech.com for more details.
Video is embedded from external source so embedding is not available.
Video is embedded from external source so download is not available.
No content is added to this lecture.
This video is a part of a lecture series from of Caltech